Laser in situ keratomileusis with a flying-spot excimer laser and a Carriazo-Barraquer microkeratome - Outcomes after 6 months

Purpose: To evaluate safety, efficiacy, predictability and refractive stability of LASIK, using a flying-spot excimer laser, 91 eyes were examined during a 6-months follow-up. Patients and methods: Consecutively, 91 eyes were enrolled in the study, each eye previously underwent LASIK with the ESIRIS excimer laser (ESIRIS, supplier: eye-tech-solutions Schwind, Kleinostheim, Germany). 91 myopic eyes (mean preoperative refraction: - 5.4 D, range: - 3 to - 13.3 D, astigmatism: - 1 D, range: 1.3 to 3.5 D) were included. A full ophthalmological examination was performed during the first week, 1, 3 and 6 months postoperatively. Results: 26% of all eyes achieved an uncorrected visual acuity of 0.8, 35% of 1.0 and 5% 1.2 6 months postoperatively. 23% of the eyes lost 1 line of best spectacle-corrected visual acuity (BSCVA), 25% gained one or more lines of BSCVA. Refraction of 90 eyes were within +/- 1 D of emmetropia 6 months postoperatively. There was no change in spherical equivalent within the interval of 6 months, all eyes were within +/- 0.5 D. Conclusion: LASIK with the ESIRIS excimer laser was an effective and safe option with good stability and predictability within the specified interval.